The dermatology CRO market is growing due to rising skin conditions, increased R&D investments, and digital tool use.

Breakthrough Therapy designation granted based on FDA’s review of available clinical evidence of safety and efficacy from all ...

Some security teams are taking a do-it-yourself approach to exposure management, according to a recent study conducted by Enterprise Strategy Group, now part of Omdia, in partnership with Tenable. But ...

Patients had less clinical worsening when treated with this “wonder drug,” as one doctor called it, within a year of ...

Trend Vision One™ Security Operations is built for the next-gen SOCHONG KONG SAR - Media OutReach Newswire - 2 October 2025 - Trend Micro Incorporated (TYO: 4704; TSE: 4704), ...

David Wells, Conservative senator for Newfoundland and Labrador, is calling for an independent review of the Churchill Falls ...

SEC seeks Zydus to submit revised protocol for phase I trial of chikungunya vaccine: Gireesh Babu, New Delhi Friday, October 3, 2025, 08:00 Hrs [IST] The Subject Expert Committee ...

ANAVEX3-71-SZ-001 achieved its primary endpoint demonstrating safety and tolerability in adults with schizophreniaEncouraging trends observed in ...

Collaboration simplifies compliance and strengthens cybersecurity resilience for SMBs through Acronis Cyber Protect ...

Coronary bifurcation lesions pose a significant challenge in interventional cardiology, accounting for approximately 15–25% ...

Detailed price information for Urogen Pharma Ltd (URGN-Q) from The Globe and Mail including charting and trades.

Investing.com -- Anavex Life Sciences Corp. (NASDAQ:AVXL) stock rose 5% after the company announced positive topline results from its Phase 2 clinical study of ANAVEX®3-71 for treating schizophrenia ...